Japan· JP-1339005F2128
ベタヒスチンメシル酸塩
A betahistine product containing ベタヒスチンメシル酸塩, registered in Japan by エーザイ, on the national reimbursement list. The same ATC class is registered in 17 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Betahistine is registered in 17 of 19 countries.
Countries holding a registration under ATC N07CA01 (betahistine), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 9 of them publish a price we can compare per daily dose
Betahistine · ATC N07CA01
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of betahistine costs, country by country.
Normalised to the WHO defined daily dose (24 mg), the median price runs from $0.11 in France to $0.44 in Switzerland — a ×4.0 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Betahistine · price per daily dose (24 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.44
- ES Spain$0.16
- FR France$0.11
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- ベタヒスチンメシル酸塩
- Manufacturer
- エーザイ
- Country
- Japan (JP)
- ATC code
- N07CA01
- ATC class
- Betahistine
- Defined daily dose
- 24 mg, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under N07CA01
Betahistine, as other registers publish it.
- FinlandAcuverCyathus Exquirere Pharmaforschungs GmbH
- PolandApoBetinaAurovitas Pharma Polska Sp. z o.o.
- PolandApoBetinaAurovitas Pharma Polska Sp. z o.o.
- PolandApoBetinaAurovitas Pharma Polska Sp. z o.o.
- CanadaAURO-BETAHISTINEAURO PHARMA INC
- CanadaAURO-BETAHISTINEAURO PHARMA INC
- CanadaAURO-BETAHISTINEAURO PHARMA INC
- PolandAuroBetinaAurovitas Pharma Polska Sp. z o.o.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d2dce812-a6a4-45cb-99ef-88b32bc51b6c GET /v1/drugs/d2dce812-a6a4-45cb-99ef-88b32bc51b6c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１２ｍｇ１錠",
"marks": "局",
"source": "mhlw",
"remarks": null,
"yj_code": "1339005F2128",
"category": "内用薬",
"price_yen": 10.8,
"generic_name": "ベタヒスチンメシル酸塩",
"product_name_jp": null,
"therapeutic_class": "1339",
"transitional_expiry": null
}See everything about betahistine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.